CVS Health Change in Assets/Liabilities 2010-2025 | CVS

CVS Health annual/quarterly change in assets/liabilities history and growth rate from 2010 to 2025. Change in assets/liabilities can be defined as represents any other changes in assets/liabilities
  • CVS Health change in assets/liabilities for the quarter ending March 31, 2025 was $1.139B, a 312.1% decline year-over-year.
  • CVS Health change in assets/liabilities for the twelve months ending March 31, 2025 was $-3.763B, a 128.93% decline year-over-year.
  • CVS Health annual change in assets/liabilities for 2024 was $-0.823B, a 157.79% decline from 2023.
  • CVS Health annual change in assets/liabilities for 2023 was $1.424B, a 79.55% decline from 2022.
  • CVS Health annual change in assets/liabilities for 2022 was $6.964B, a 137.92% increase from 2021.
CVS Health Annual Change in Assets/Liabilities
(Millions of US $)
2024 $-823
2023 $1,424
2022 $6,964
2021 $2,927
2020 $2,873
2019 $1,182
2018 $-149
2017 $-671
2016 $125
2015 $253
2014 $-361
2013 $-31
2012 $14
2011 $-467
2010 $-258
2009 $84
Sector Industry Market Cap Revenue
Medical Medical Services $76.179B $372.809B
CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $134.174B 25.17
Elevance Health (ELV) United States $86.874B 11.21
Cencora (COR) United States $56.230B 19.56
DiDi Global (DIDIY) China $23.297B 35.36
Natera (NTRA) United States $20.821B 0.00
BioMerieux (BMXMF) France $15.355B 0.00
Solventum (SOLV) United States $12.571B 13.31
EUROFINS SCIENT (ERFSF) Luxembourg $12.522B 0.00
CochLear (CHEOY) Australia $11.391B 0.00
Revvity (RVTY) United States $10.665B 18.35
ICON (ICLR) Ireland $10.255B 9.53
Viatris (VTRS) United States $9.976B 3.43
Doximity (DOCS) United States $9.570B 44.57
Avantor (AVTR) United States $8.763B 12.73
HealthEquity (HQY) United States $8.657B 42.59
Medpace Holdings (MEDP) United States $8.422B 22.37
Sonic Healthcare (SKHHY) Australia $8.157B 0.00
Charles River Laboratories (CRL) United States $6.660B 13.05
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
BrightSpring Health Services (BTSG) United States $3.994B 36.97
Bausch + Lomb (BLCO) Canada $3.976B 23.44
Sotera Health (SHC) United States $3.480B 19.77
Surgery Partners (SGRY) United States $2.896B 37.67
Alignment Healthcare (ALHC) United States $2.867B 0.00
Concentras Parent (CON) United States $2.744B 15.86
Organon (OGN) United States $2.259B 2.40
Ardent Health Partners (ARDT) United States $2.117B 9.02
GeneDx Holdings (WGS) United States $1.921B 73.99
Premier (PINC) United States $1.910B 14.50
Progyny (PGNY) United States $1.791B 39.42
PACS (PACS) United States $1.494B 0.00
GoodRx Holdings (GDRX) United States $1.364B 27.29
Teladoc Health (TDOC) United States $1.211B 0.00
Pediatrix Medical (MD) United States $1.200B 9.13
Establishment Labs Holdings (ESTA) $1.066B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.998B 0.00
CareDx (CDNA) United States $0.953B 14.88
Agilon Health (AGL) United States $0.911B 0.00
Nutex Health (NUTX) United States $0.901B 13.61
AMN Healthcare Services Inc (AMN) United States $0.830B 7.77
QDM (QDMI) Hong Kong, SAR China $0.729B 0.00
Embecta (EMBC) United States $0.614B 4.14
InnovAge Holding (INNV) United States $0.543B 0.00
LifeMD (LFMD) United States $0.523B 0.00
Enhabit (EHAB) United States $0.520B 42.75
Auna S.A (AUNA) Luxembourg $0.505B 11.37
Sonida Senior Living (SNDA) United States $0.465B 0.00
SBC Medicals (SBC) United States $0.398B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.388B 0.00
Oncology Institute (TOI) United States $0.226B 0.00
Beauty Health (SKIN) United States $0.217B 0.00
Performant Healthcare (PHLT) United States $0.214B 0.00
KindlyMD (KDLY) United States $0.150B 0.00
DocGo (DCGO) United States $0.137B 22.33
OncoCyte (OCX) United States $0.098B 0.00
So-Young (SY) China $0.088B 0.00
Sera Prognostics (SERA) United States $0.071B 0.00
Ascend Wellness Holdings (AAWH) United States $0.063B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.057B 0.00
Biodesix (BDSX) United States $0.052B 0.00
Pheton Holdings (PTHL) China $0.040B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.031B 0.00
Basel Medical Group (BMGL) Singapore $0.022B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
ModivCare (MODV) United States $0.013B 0.00
Intelligent Bio Solutions (INBS) United States $0.009B 0.00
Co-Diagnostics (CODX) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00